News 2016
HIV Can Persist in Body Despite Drug Therapy
Tracking the virus
Even when blood tests of HIV patients on antiretroviral drugs show no sign of the AIDS-causing virus, it can still be replicating in lymphoid tissue, researchers report.
Zepatier Approved for Chronic Hepatitis C
Zepatier, a fixed-dose two drug combination, has been approved for the treatment of Hepatitis C
Zepatier (a combination of elbasvir and grazoprevir) has been approved by the U.S. Food and Drug Administration to treat chronic infection with the hepatitis C virus, genotypes 1 and 4.
What Drives Me? Getting to an AIDS-Free Generation
Douglas M. Brooks, MSW, Director of the Office of National AIDS Policy
Recently, I had the chance to sit down with my good friend and colleague, Jamal Brown, Press Secretary for the White House Office of Management and Budget, to talk about priorities for achieving the goals of the National HIV/AIDS Strategy through 2016 and my personal connection to HIV/AIDS work. Check out our chat here:
Read more: What Drives Me? Getting to an AIDS-Free Generation
New Approach Might Boost HIV Testing Rates
Patient doesn't opt out and takes HIV test
Telling people they'll be screened for HIV unless they decline to be tested -- an approach known as "opt-out" testing -- could significantly increase the number of patients who agree to be tested, new research suggests.
States Simplify Medicaid Sign-Ups
Patient navigator demonstrates simplified sign-up process
Getting on Medicaid has never been so easy.
In the past two years, 31 states and the District of Columbia have expanded eligibility for Medicaid under the Affordable Care Act, but even more have simplified sign-ups and renewals, according to a 50-state survey released Thursday.